Cancer
Mayo Clinic researchers used a new approach to chemotherapy to more than double the typical survival rate for patients with stomach cancer and peritoneal metastasis, which is cancer that has spread to the lining of the abdominal cavity.
Latest stories
No posts available.
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community